Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsVindhya Udhane, Marja T. Nevalainen, Cristina Maranto et al.|Molecular Cancer Therapeutics|2019Cited by 26
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Marja T. Nevalainen, Liang Wang et al.|Cancers|2021Cited by 24
Stat5 induces androgen receptor ( <i>AR</i> ) gene transcription in prostate cancer and offers a druggable pathway to target AR signalingCristina Maranto, Marja T. Nevalainen, Lavannya Sabharwal et al.|Science Advances|2024Cited by 10
The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line treatment.Vindhya Udhane, Marja T. Nevalainen, Cristina Maranto et al.|Journal of Clinical Oncology|2019Cited by 2